SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-20-000018
Filing Date
2020-02-18
Accepted
2020-02-18 17:14:13
Documents
1
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158206403696552.html 4  
1 FORM 4 wf-form4_158206403696552.xml 4 4055
  Complete submission text file 0001485003-20-000018.txt   5549
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142
Business Address
Cannell Thomas R (Reporting) CIK: 0001637822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 20626368